Stocks
ResMed (RMD) EBITDA margin US GAAP (year values) |
|||||||||
| 2023 | 2023 | 2024 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 31.7% | 32.2% | 36.1% | 32.7% | 37.2% | 38.0% | ||
| Changes by years, y/y, % | -1pp | +0pp | +4pp | -3pp | +4pp | +2.1% | |||
ResMed. EBITDA margin, %
ResMed. EBITDA margin, changes, pp
ResMed (RMD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| EBITDA margin, % | ? | 36.4% | 39.5% | 37.7% | 39.8% | 34.9% | 38.0% | |
| Changes by years, y/y, % | +0pp | +10pp | +2pp | +2pp | -1pp | |||
| Changes by quarters, q/q, % | -1pp | +3pp | -2pp | +2pp | -5pp | |||
